Impact of the Glycemic Control and Duration of Type 2 Diabetes on Vitamin D Level and Cardiovascular Disease Risk
Table 5
One-way ANOVA and post hoc test results of 25(OH)D and bone panel variable among study subgroups.
Groups
FBG (mmol/l)
HbA1c (mol/mol)
25(OH)D (nmol/l)
Calcium (mmol/l)
PTH (ng/l)
PO4 (mmol/l)
ALP (U/l)
Normal
NC
NU
LC
LU
(between group)
41.484
102.172
4.973
1.184
3.898
2.879
4.657
(value)
0.001
0.001
0.001
0.322
0.005
0.026
0.002
Post hoc test
N vs. NC
0.148
0.007
0.826
0.969
0.977
0.575
0.626
N vs. NU
0.001
0.001
1.000
0.996
0.847
0.776
0.001
N vs. LC
0.005
0.001
0.003
0.592
0.011
0.469
0.989
N vs. LU
0.001
0.001
0.154
1.000
0.068
0.997
0.643
NC vs. NU
0.001
0.001
0.784
0.882
0.988
0.100
0.049
LC vs. LU
0.001
0.001
0.619
0.611
0.964
0.690
0.899
NC vs. LC
0.745
0.480
0.068
0.231
0.056
0.018
0.889
NU vs. LU
0.606
0.053
0.168
0.997
0.647
0.916
0.046
Note: data are presented as the . value for differences between groups according to ANOVA, significant if . 25(OH)D: 25-hydroxyvitamin D; PTH: parathyroid hormone; PO4: phosphorus; NC: newly diagnosed controlled; NU: newly diagnosed uncontrolled; LU: long-lasting diagnosed control; LU: long-lasting diagnosed uncontrolled.
